… Transcatheter closure of perimembranous ventricular septal defects using the new Amplatzer
… : Immediate and medium-term results in a canine model. Interact Cardiovasc Thorac Surg …

… in real applications, such astheirtensile strength, elastic recovery ability, and release/recycle
sensation, thus meeting the requirements for evaluation of new devices and teaching tasks. …

… rate, other new devices have shown good results for closure of perimembranous VSDs.
However, the transcatheter technique is slightly complicated to perform, and concerns about …

… for device closure of ventricular septal defects, including percutaneous and hybrid perventricular
approaches. The available devices … A new trivial or mild aortic regurgitation was seen in …

… Here, we fabricated a fully degradable ventricular septum defect (VSD) occluder consisting
of … development of new-generation degradable medical devices for structural heart diseases. …

… new devices, a new type of technique was invented, by some surgeons for closing muscular
… The first real case practice of this surgery by perventricular closure of VSD was fulfilled on …

… device closure of perimembranous and muscular VSDs, as well as transcatheter and
intraoperative closure … Initial outcomes with this new device were promising, with a report later that …

… In this chapter we will group ventricular septal defects as: … four chamber demonstrating a
muscular ventricular septal defect. There is a defect in the muscular septum evident in the two …

… To assess the mid-term safety and efficacy of transthoracic perimembranous ventricular
septal defect (Pm-VSD) closure using a new biodegradable device. Implantation entailed right …

… treatments for ventricular septal defects (VSDs) mainly include 3 approaches: conventional
surgical repair (CSR), transcatheter device closure (TDC), and perventricualr device closure (…